Atlas Trials

A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

Clinical trial NCT04394234 · COMPLETED

Trial details

NCT number
NCT04394234
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Study type
OBSERVATIONAL
Uterine Hemorrhage
Start date
2020-05-15
Primary completion
2020-06-01
Enrollment
961985

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.